These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 136058)

  • 21. Anti-c5a ameliorates coagulation/fibrinolytic protein changes in a rat model of sepsis.
    Laudes IJ; Chu JC; Sikranth S; Huber-Lang M; Guo RF; Riedemann N; Sarma JV; Schmaier AH; Ward PA
    Am J Pathol; 2002 May; 160(5):1867-75. PubMed ID: 12000738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential diagnosis of localized and systemic amyloidosis based on coagulation and fibrinolysis parameters.
    Suga N; Miura N; Kitagawa W; Morita H; Banno S; Imai H
    Amyloid; 2012 Jun; 19(2):61-5. PubMed ID: 22417630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prothrombin conversion and thrombin decay in patients with cirrhosis-role of prothrombin and antithrombin deficiencies.
    Sinegre T; Abergel A; Lecompte T; Lebreton A
    J Thromb Haemost; 2024 May; 22(5):1347-1357. PubMed ID: 38309434
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thrombin formation and effect of unfractionated heparin during pediatric cardiac catheterization.
    Chen D; Långström S; Petäjä J; Heikinheimo M; Pihkala J
    Catheter Cardiovasc Interv; 2013 Jun; 81(7):1174-9. PubMed ID: 22915548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Kinetic alterations of coagulation-anticoagulation and the fibrinolytic system in patients with epidemic hemorrhagic fever and their significance].
    Dong CR
    Zhonghua Yi Xue Za Zhi; 1988 Dec; 68(12):678-81, 46. PubMed ID: 2907863
    [No Abstract]   [Full Text] [Related]  

  • 26. A new assay for the measurement of total progressive antithrombin.
    Lane JL; Bird P; Rizza CR
    Br J Haematol; 1975 May; 30(1):103-15. PubMed ID: 53064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Maternal and neonatal hemostatic correlation.
    Saleh AA; Stowers MA; Eldridge DM; Dorey LG; Hirokawa S; Dombrowski MP; Bottoms SF; Cotton DB; Mammen EF
    Thromb Res; 1992 Dec; 68(4-5):425-8. PubMed ID: 1290171
    [No Abstract]   [Full Text] [Related]  

  • 28. Elevated levels of prothrombin fragment 1 + 2 indicate high risk of thrombosis.
    Ota S; Wada H; Abe Y; Yamada E; Sakaguchi A; Nishioka J; Hatada T; Ishikura K; Yamada N; Sudo A; Uchida A; Nobori T
    Clin Appl Thromb Hemost; 2008 Jul; 14(3):279-85. PubMed ID: 18160575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dysfibrinogenemia: a case with thrombosis (fibrinogen Richfield) and an overview of the clinical and laboratory spectrum.
    Schorer AE; Singh J; Basara ML
    Am J Hematol; 1995 Nov; 50(3):200-8. PubMed ID: 7485081
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Protein C and D-dimer are related to portal vein thrombosis in patients with liver cirrhosis.
    Zhang D; Hao J; Yang N
    J Gastroenterol Hepatol; 2010 Jan; 25(1):116-21. PubMed ID: 19686413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Incidence of deep venous thrombosis (DVT) in patients undergoing thoracotomy and changes of hemostasis].
    Yuan XZ; Wu XM; Chen M; Yuan JY; Zhang SS
    Beijing Da Xue Xue Bao Yi Xue Ban; 2004 Oct; 36(5):529-32. PubMed ID: 15489937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
    Nishiyama T; Kohno Y; Koishi K
    Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fibrinogen, D-dimer and thrombin-antithrombin complexes in a random population sample: relationships with other cardiovascular risk factors.
    Giansante C; Fiotti N; Cattin L; Da Col PG; Calabrese S
    Thromb Haemost; 1994 May; 71(5):581-6. PubMed ID: 8091384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Importance of anticoagulant proteins in chronic liver diseases.
    Gürsoy S; Başkol M; Torun E; Yurci A; Soyuer I; Eser B; Güven K; Ozbakir O; Yücesoy M
    Turk J Gastroenterol; 2005 Sep; 16(3):129-33. PubMed ID: 16245221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Nonenzymatic fibrinolysis].
    Dzhurdzhev A; Atanasov K
    Vutr Boles; 1981; 20(3):18-22. PubMed ID: 6455858
    [No Abstract]   [Full Text] [Related]  

  • 36. [Haemostatic activation in head injury].
    Sánchez-Polo CM; Suarez-Pinilla MA; Nebra-Puertas A; Monton-Dito JM; Millastre-Benito A; Salvo-Callen L
    Neurocirugia (Astur); 2003 Sep; 14(4):309-21; discussion 321-2. PubMed ID: 14506554
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thrombin binds to soluble fibrin degradation products where it is protected from inhibition by heparin-antithrombin but susceptible to inactivation by antithrombin-independent inhibitors.
    Weitz JI; Leslie B; Hudoba M
    Circulation; 1998 Feb; 97(6):544-52. PubMed ID: 9494024
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular composition and biological properties of soluble fibrin polymers encountered in thrombotic states.
    Bang NU; Hansen MS; Smith GF; Latallo ZS; Chang ML; Mattler LE
    Ser Haematol; 1973; 6(4):494-512. PubMed ID: 4277578
    [No Abstract]   [Full Text] [Related]  

  • 39. In vivo behaviour of some antithrombin III-protease complexes.
    Lam LS; Regoeczi E; Hatton MW
    Br J Exp Pathol; 1979 Apr; 60(2):151-60. PubMed ID: 156039
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemostasis activation during esophageal variceal sclerotherapy with thrombin in cirrhotics.
    Fujii Y; Sugawa C; Ozawa T; Nakumura R; Brown-Castillo J; Mammen EF
    Am Surg; 1991 Apr; 57(4):222-5. PubMed ID: 1711300
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.